576 Blocking FGFR2 and SHP2 can effectively suppress tumor progression in gastric cancers with FGFR2 alteration

• Yue Wang,
• Baorui Liu,
• Yue Zhang,
• Jia Wei,
• Hanbing Wang,
• Lixia Yu

Affiliations

Yue Wang

2Clinical Cancer Institute of Nanjing University, Nanjing, Jiangsu, China

Baorui Liu

The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China

Yue Zhang

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

Jia Wei

3The Comprehensive Cancer Centre of Drum Tower Hospital, Nanjing, Jiangsu, China

Hanbing Wang

1The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China., Nanjing, China

Lixia Yu

1The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China., Nanjing, China